IL326563A - Crystalline forms of a bet inhibitor - Google Patents
Crystalline forms of a bet inhibitorInfo
- Publication number
- IL326563A IL326563A IL326563A IL32656326A IL326563A IL 326563 A IL326563 A IL 326563A IL 326563 A IL326563 A IL 326563A IL 32656326 A IL32656326 A IL 32656326A IL 326563 A IL326563 A IL 326563A
- Authority
- IL
- Israel
- Prior art keywords
- crystalline forms
- bet inhibitor
- bet
- inhibitor
- crystalline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363578834P | 2023-08-25 | 2023-08-25 | |
| PCT/US2024/043727 WO2025049339A2 (en) | 2023-08-25 | 2024-08-23 | Crystalline forms of a bet inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326563A true IL326563A (en) | 2026-04-01 |
Family
ID=94820218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326563A IL326563A (en) | 2023-08-25 | 2024-08-23 | Crystalline forms of a bet inhibitor |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2024329991A1 (en) |
| IL (1) | IL326563A (en) |
| WO (1) | WO2025049339A2 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150361139A1 (en) * | 2013-01-30 | 2015-12-17 | Sandoz Ag | Crystalline form of linaclotide |
| KR20210064310A (en) * | 2018-09-22 | 2021-06-02 | 토렌트 파마슈티칼스 리미티드 | Method for the preparation of pyrazole compounds |
| EP3997070A4 (en) * | 2019-07-02 | 2023-07-26 | Nuvation Bio Inc. | Heterocyclic compounds as bet inhibitors |
| US20220041606A1 (en) * | 2020-07-28 | 2022-02-10 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| EP4347615B1 (en) * | 2021-06-01 | 2025-05-21 | Synthon B.V. | Process for making melflufen or a salt thereof |
-
2024
- 2024-08-23 IL IL326563A patent/IL326563A/en unknown
- 2024-08-23 WO PCT/US2024/043727 patent/WO2025049339A2/en active Pending
- 2024-08-23 AU AU2024329991A patent/AU2024329991A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025049339A3 (en) | 2025-05-15 |
| AU2024329991A1 (en) | 2026-03-05 |
| WO2025049339A2 (en) | 2025-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202209617B (en) | Crystalline hydrate of a jak inhibitor compound | |
| SG11202107225SA (en) | Crystalline form of a cdk inhibitor | |
| IL321053A (en) | Crystalline forms of a her2 inhibitor | |
| RS67809B1 (en) | Crystalline forms of a btk inhibitor | |
| IL317847A (en) | Salts of sos1 inhibitors | |
| IL326463A (en) | Crystalline forms of a pi3k inhibitor and uses of same | |
| IL316075A (en) | Crystalline form of lanifibranor | |
| IL321007A (en) | Crystalline forms of a piperidine inhibitor of slc6a19 function | |
| IL310234A (en) | Salts and solid state forms of a kif18a inhibitor compound | |
| IL289929A (en) | Crystalline forms of a cd73 inhibitor | |
| IL325861A (en) | Crystalline forms of a menin inhibitor | |
| IL288484A (en) | Crystalline salt forms of a kinase inhibitor | |
| EP3923948A4 (en) | Crystalline forms of a jak2 inhibitor | |
| IL315411A (en) | Pure forms of crystalline aticaprant | |
| IL326563A (en) | Crystalline forms of a bet inhibitor | |
| IL285427A (en) | Crystalline forms of a jak2 inhibitor | |
| IL321665A (en) | Crystalline forms of a lpa1 antagonist | |
| GB202005114D0 (en) | Crystalline Forms of a Pharmaceutical Compound | |
| IL304683A (en) | Crystalline form of a piperazinyl-thiazole derivative | |
| PT4387730T (en) | Solid forms of a rock inhibitor | |
| IL292847A (en) | Crystalline forms of a magl inhibitor | |
| GB202214708D0 (en) | Crystalline form of a rock inhibitor | |
| GB202213103D0 (en) | Crystalline form of a rock inhibitor | |
| HK40086278A (en) | Crystalline forms of a tyk2 inhibitor | |
| HK40110076A (en) | Crystalline forms of a ripk1 inhibitor |